Lawlis V Bryan
CIK 0001247681
Director
Filings
13
Latest May 22, 2025
Issuers covered
3
Showing
13 of 13
Page 1
Track record
6 of 6 open-market trades scored (100% price coverage). Returns are signed: a +10% move on a sale shows as -10% (insider was wrong).
| Horizon | Trades | Win rate | Avg | Median | Best | Worst |
|---|---|---|---|---|---|---|
| 30 days | 6 | 67% | +0.9% | +1.7% | +37.3% | -24.9% |
| 90 days | 6 | 50% | +0.2% | +1.8% | +11.1% | -17.2% |
| 180 days | 6 | 50% | +4.4% | -1.7% | +33.9% | -7.6% |
| 365 days | 6 | 50% | +3.7% | -4.6% | +69.0% | -31.5% |
Issuers
Companies where Lawlis V Bryan has filed
| Ticker | Issuer | Filings | Last filed |
|---|---|---|---|
| GERN | Geron Corp | 7 | May 22, 2025 |
| BMRN | Biomarin Pharmaceutical Inc | 5 | May 24, 2023 |
| SYRE | Spyre Therapeutics, Inc. | 1 | Jun 9, 2022 |
All filings
13 Form 4 / 4-A filings, newest first
| Filed | Top transaction | Shares | Price | Value | ||
|---|---|---|---|---|---|---|